Tag: Atrial Fibrillation
USPSTF: Evidence Still Lacking for Atrial Fibrillation Screening
Evidence currently inadequate for assessing the balance of benefits and harms of screening for atrial fibrillation in asymptomatic adults
Frail Patients With Nonvalvular A-Fib Less Likely to Receive Anticoagulants
Frail patients with nonvalvular atrial fibrillation also less likely to receive a direct oral anticoagulant versus warfarin
AI-Based Analysis of ECG May Help Assess A-Fib Risk
Predictive utility comparable for CHARGE AF clinical risk score, artificial intelligence-enabled analysis of 12-lead electrocardiogram
Incidence of Atrial Fibrillation Up After Breast Cancer Diagnosis
Breast cancer stage strongly linked to development of AF; new-onset AF after breast cancer diagnosis linked to increased cardiovascular mortality
Diabetes Patients Less Often Perceive Atrial Fibrillation Symptoms
Those with diabetes and a-fib have worse quality of life and more cardiac and neurological morbidities than those without diabetes
Screening Seniors for A-Fib Reduces Risk for Adverse Outcomes
Reduction seen in combined end point of stroke, systemic embolism, bleeding leading to hospitalization, death
Individual A-Fib Episodes Tied to Recent Alcohol Intake
AF episodes also linked to higher odds of peak blood alcohol concentration, total area under curve of alcohol exposure
Working Night Shift May Up Risk for Atrial Fibrillation
Risk increased for both current and long-term exposure to night shift work regardless of genetic risk for atrial fibrillation
Racial/Ethnic Disparities Seen in Anticoagulant Initiation for A-Fib
Disparities seen among VA patients both for initiating any anticoagulant therapy and for initiating direct-acting oral anticoagulant use
Early Rhythm Control Key in A-Fib and Heart Failure
Reduction seen in composite primary outcomes of CV death, stroke, hospitalization for worsening of heart failure or ACS
